RPAM
PTLA

Rhenman & Partners Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Rhenman & Partners Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-241,964
Closed -$4.72M – 99
2018
Q4 		$4.72M Sell
241,964
-338
-0.1% -$6.95K 0.54% 58
2018
Q3 		$6.45M Sell
242,302
-110,000
-31% -$3.59M 0.65% 58
2018
Q2 		$13.3M Buy
352,302
+82,054
+30% +$3.14M 1.36% 34
2018
Q1 		$8.83M Buy
270,248
+59,095
+28% +$2.59M 1.09% 41
2017
Q4 		$10.3M Sell
211,153
-86,247
-29% -$4.36M 1.39% 26
2017
Q3 		$16.1M Buy
297,400
+186,595
+168% +$11M 2.05% 15
2017
Q2 		$6.22M Sell
110,805
-10,000
-8% -$401K 0.89% 43
2017
Q1 		$4.73M Hold
120,805
– – 0.75% 52
2016
Q4 		$2.71M Hold
120,805
– – 0.52% 65
2016
Q3 		$2.74M Buy
120,805
+15,805
+15% +$371K 0.44% 70
2016
Q2 		$2.48M Hold
105,000
– – 0.44% 68
2016
Q1 		$2.14M Buy
105,000
+43,000
+69% +$1.36M 0.43% 73
2015
Q4 		$3.19M Sell
62,000
-9,000
-13% -$436K 0.48% 66
2015
Q3 		$3.03M Sell
71,000
-5,000
-7% -$241K 0.48% 64
2015
Q2 		$3.46M Buy
+76,000
New +$3.06M 0.42% 77

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Rhenman & Partners Asset Management's PTLA Position: Q1 2019 in Review

Rhenman & Partners Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2019, closing a stake of 241,964 shares — an estimated $4.72M sold.

Rhenman & Partners Asset Management first reported a position in PTLA in Q2 2015 and held it in 15 quarters. The position peaked at $16.1M in Q3 2017. 209 funds tracked by Wall St. Rank hold PTLA as of Q1 2019.

  • Rhenman & Partners Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 241,964 Portola Pharmaceuticals, Inc. shares in Q1 2019, an estimated $4.72M.
  • Rhenman & Partners Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2015 and held it in 15 quarters.
  • Rhenman & Partners Asset Management's Portola Pharmaceuticals, Inc. position peaked at $16.1M in Q3 2017.
  • 209 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2019.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2019, filed 11 Apr 2019.